The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Role of the pharmacist in reducing healthcare costs: current insights
Open accessAbstract
Global healthcare expenditure is escalating at an unsustainable rate. Money spent on medicines and managing medication-related problems continues to grow. The high prevalence of medication errors and inappropriate prescribing is a major issue within healthcare systems, and can often contribute to adverse drug events, many of which are preventable. As a result, there is a huge opportunity for pharmacists to have a significant impact on reducing healthcare costs, as they have the expertise to detect, resolve, and prevent medication errors and medication-related problems. The development of clinical pharmacy practice in recent decades has resulted in an increased number of pharmacists working in clinically advanced roles worldwide. Pharmacist-provided services and clinical interventions have been shown to reduce the risk of potential adverse drug events and improve patient outcomes, and the majority of published studies show that these pharmacist activities are cost-effective or have a good cost:benefit ratio. This review demonstrates that pharmacists can contribute to substantial healthcare savings across a variety of settings. However, there is a paucity of evidence in the literature highlighting the specific aspects of pharmacists' work which are the most effective and cost-effective. Future high-quality economic evaluations with robust methodologies and study design are required to investigate what pharmacist services have significant clinical benefits to patients and substantiate the greatest cost savings for healthcare budgets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Adherence to Long-Term Therapies: Evidence for Action
De Geest, S., & Sabaté, E. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00091-4 · Cited by 6,272
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Kirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., Walley, T. J., Farrar, K., Park, B. K., & Breckenridge, A. M. (2004) · BMJ · doi:10.1136/bmj.329.7456.15 · Cited by 3,230
DiMatteo, M. R. (2004) · Medical Care · doi:10.1097/01.mlr.0000114908.90348.f9 · Cited by 2,169 · cited 1×
“Even though good medication adherence correlates with positive health outcomes,(35) it is estimated that between 20% and 50% of patients in developed countries may be nonadherent with their medications.(36,37) Nonadherence is associated with potential disease progression, pharmacotherapeutic failure, and hospitalizati…”
Clinical consequences of polypharmacy in elderly
Maher, R. L., Hanlon, J., & Hajjar, E. R. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.827660 · Cited by 1,938
Pharmacist Participation on Physician Rounds and Adverse Drug Events in the Intensive Care Unit
Leape, L. L. (1999) · JAMA · doi:10.1001/jama.282.3.267 · Cited by 1,599
The Global Burden of Chronic Diseases: Overcoming Impediments to Prevention and Control
Yach, D., Hawkes, C., Gould, C. L., & Hofman, K. J. (2004) · JAMA · doi:10.1001/jama.291.21.2616 · Cited by 1,369
A meta-analysis of the association between adherence to drug therapy and mortality
Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A. (2006) · BMJ · doi:10.1136/bmj.38875.675486.55 · Cited by 1,353 · cited 1×
“34 Even though good medication adherence correlates with positive health outcomes, 35 it is estimated that between 20% and 50% of patients in developed countries may be nonadherent with their medications.”
Designing Health Care for the Most Common Chronic Condition—Multimorbidity
Tinetti, M. E., Fried, T. R., & Boyd, C. M. (2012) · JAMA · doi:10.1001/jama.2012.5265 · Cited by 1,005
Relationship between medication errors and adverse drug events
Bates, D. W., Boyle, D. L., Vliet, M. B. V., Schneider, J., & Leape, L. (1995) · Journal of General Internal Medicine · doi:10.1007/bf02600255 · Cited by 981
Clinical Pharmacists and Inpatient Medical Care: A Systematic Review
Kaboli, P. J., Hoth, A. B., McClimon, B. J., & Schnipper, J. L. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.9.955 · Cited by 882
Lee, J. K., Grace, K. A., & Taylor, A. J. (2006) · JAMA · doi:10.1001/jama.296.21.joc60162 · Cited by 807
Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies.
BEIJER, H. J. M., & Blaey, C. J. D. (2002) · Pharmacy World & Science · doi:10.1023/a:1015570104121 · Cited by 749
Bormate, A. B., Leboit, P. E., & McCalmont, T. H. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.8.1020 · Cited by 731
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-Analysis of Prospective Studies
LAZAROU, J., POMERANZ, B. H., & COREY, P. N. (1999) · Survey of Anesthesiology · doi:10.1097/00132586-199902000-00059 · Cited by 670
Chiquette, E., Amato, M. G., & Bussey, H. I. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.15.1641 · Cited by 596
Mekonnen, A. B., McLachlan, A. J., & Brien, J.-A. E. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010003 · Cited by 532
Kucukarslan, S. N., Peters, M., Mlynarek, M., & Nafziger, D. A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.17.2014 · Cited by 514
Mossialos, E., Courtin, E., Naci, H., Benrimoj, S., Bouvy, M., Farris, K., Noyce, P., & Sketris, I. (2015) · Health Policy · doi:10.1016/j.healthpol.2015.02.007 · Cited by 465 · cited 1×
“The expanded role of pharmacists managing chronic diseases is commensurate with the extensive training and knowledge associated with the profession.(28)”
Medication Adherence Leads To Lower Health Care Use And Costs Despite Increased Drug Spending
Roebuck, M. C., Liberman, J. N., Gemmill-Toyama, M., & Brennan, T. A. (2011) · Health Affairs · doi:10.1377/hlthaff.2009.1087 · Cited by 460
Leendertse, A., Egberts, T. C. G., Stoker, L., & van den Bemt, P. M. L. A. (2008) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 360
Bunting, B. A., Smith, B. H., & Sutherland, S. E. (2008) · Journal of the American Pharmacists Association · doi:10.1331/japha.2008.07140 · Cited by 329
Evidence of the Economic Benefit of Clinical Pharmacy Services: 1996–2000
Schumock, G. T., Butler, M. G., Meek, P. D., Vermeulen, L. C., Arondekar, B. V., & Bauman, J. L. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.1.113.31910 · Cited by 285
Garrick, R. (2009) · Yearbook of Medicine · doi:10.1016/s0084-3873(09)79549-5 · Cited by 282
Medication compliance: a healthcare problem.
Berg, J. S., Dischler, J. E., Wagner, D. J., Raia, J., & Palmer-Shevlin, N. L. (1993) · PubMed · Cited by 272
The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines
Nichol, K. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00070-7 · Cited by 265
Schumock, G. T., Meek, P. D., Ploetz, P. A., & Vermeulen, L. C. (1997) · PubMed · Cited by 247
Dooley, M. J., Allen, K. M., Doecke, C. J., Galbraith, K. J., Taylor, G. R., Bright, J., & Carey, D. L. (2004) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.02029.x · Cited by 246
Klopotowska, J. E., Kuiper, R., van Kan, H. J., de Pont, A.-C., Dijkgraaf, M. G., Lie-A-Huen, L., Vroom, M. B., & Smorenburg, S. M. (2010) · Critical Care · doi:10.1186/cc9278 · Cited by 226
Economic Evaluations of Clinical Pharmacy Services: 2006–2010
Touchette, D. R., Doloresco, F., Suda, K. J., Perez, A., Turner, S., Jalundhwala, Y., Tangonan, M. C., & Hoffman, J. M. (2014) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1414 · Cited by 222
Dwyer, L. L., Han, B., Woodwell, D. A., & Rechtsteiner, E. A. (2010) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2010.01.001 · Cited by 209
Blenkinsopp, A., Bond, C., & Raynor, D. K. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04331.x · Cited by 202
Counting the Costs of Drug-Related Adverse Events
White, T. J., Arakelian, A., & Rho, J. P. (1999) · PharmacoEconomics · doi:10.2165/00019053-199915050-00003 · Cited by 197
Kopp, B. J., Mrsan, M., Erstad, B. L., & Duby, J. J. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060674 · Cited by 196
Family physicians as team leaders: "time" to share the care.
Yarnall, K. S. H., Østbye, T., Krause, K. M., Pollak, K. I., Gradison, M., & Michener, J. L. (2009) · Europe PMC (PubMed Central) · Cited by 195
Goad, J. A., Taitel, M. S., Fensterheim, L. E., & Cannon, A. E. (2013) · The Annals of Family Medicine · doi:10.1370/afm.1542 · Cited by 187
The state of the world's pharmacy: a portrait of the pharmacy profession
Anderson, S. (2002) · Journal of Interprofessional Care · doi:10.1080/1356182021000008337 · Cited by 186
Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta‐analysis
Miguel, A., Azevedo, L. F., Araújo, M., & Pereira, A. C. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3309 · Cited by 181
Economic effects of pharmacists on health outcomes in the United States: A systematic review
Chisholm-Burns, M. A., Graff Zivin, J. S., Lee, J. K., Spivey, C. A., Slack, M., Herrier, R. N., Hall-Lipsy, E., Abraham, I., & Palmer, J. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100077 · Cited by 171
Economic effects of clinical pharmacy interventions: A literature review
De Rijdt, T., Willems, L., & Simoens, S. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070506 · Cited by 164
Pharmacists and prescribing rights: review of international developments.
Emmerton, L., Marriott, J., Bessell, T., Nissen, L. M., & Dean, L. (2005) · PubMed · Cited by 161
The Role of the Pharmacist in Optimizing Pharmacotherapy in Older People
Spinewine, A., Fialová, D., & Byrne, S. (2012) · Drugs & Aging · doi:10.2165/11631720-000000000-00000 · Cited by 160
Self-citationErrors in medication history at hospital admission: prevalence and predicting factors
Hellström, L., Bondesson, Å., Höglund, P., & Eriksson, T. (2012) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-12-9 · Cited by 154
Effectiveness of clinical pharmacy services: an overview of systematic reviews (2000–2010)
Rotta, I., Salgado, T. M., Silva, M. L., Correr, C. J., & Fernández-Llimós, F. (2015) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-015-0137-9 · Cited by 154
Pande, S., Hiller, J. E., Nkansah, N., & Bero, L. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010398 · Cited by 150
Pharmacist- versus physician-obtained medication histories
Reeder, T. A., & Mutnick, A. H. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070292 · Cited by 147
Identifying the Optimal Role for Pharmacists in Care Transitions: A Systematic Review
Ensing, H. T., Stuijt, C. C. M., van den Bemt, B. J. F., van Dooren, A. A., Karapinar‐Çarkit, F., Koster, E. S., & Bouvy, M. L. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.8.614 · Cited by 145
Clinical pharmacy‐led disease and medicine management programme for patients with COPD
Khdour, M. R., Kidney, J. C., Smyth, B. M., & McElnay, J. C. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03493.x · Cited by 144
Non-Traditional Settings for Influenza Vaccination of Adults
Prosser, L. A., O’Brien, M. A., Molinari, N., Hohman, K. H., Nichol, K. L., Messonnier, M. L., & Lieu, T. A. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826020-00006 · Cited by 141
Marston, C., Meltzer, H., & Majeed, A. (2005) · BMJ · doi:10.1136/bmj.38519.440266.8f · Cited by 137
Schmiedl, S., Rottenkolber, M., Hasford, J., Rottenkolber, D., Farker, K., Drewelow, B., Hippius, M., Saljé, K., & Thürmann, P. (2014) · Drug Safety · doi:10.1007/s40264-014-0141-3 · Cited by 136
Karnon, J. D., Campbell, F., & Czoski‐Murray, C. (2009) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2008.01000.x · Cited by 133
Economic Evaluations of Clinical Pharmacy Services: 2001–2005
Pérez, A., Doloresco, F., Hoffman, J. M., Meek, P. D., Touchette, D. R., Vermeulen, L. C., & Schumock, G. T. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.1.128 · Cited by 126
Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs
Ranchon, F., Salles, G., Späth, H.-M., Schwiertz, V., Vantard, N., Parat, S., Broussais, F., You, B., Tartas, S., Souquet, P. J., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-478 · Cited by 121
The increasing role of pharmacists in antimicrobial stewardship in English hospitals
Wickens, H. J., Farrell, S., Ashiru-Oredope, D. A. I., Jacklin, A., Holmes, A. H., Cooke, J., Sharland, M., Ashiru-Oredope, D. A. I., McNulty, C. A. M., Dryden, M., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt241 · Cited by 117
Halvorsen, K. H., Ruths, S., Granås, A. G., & Viktil, K. K. (2010) · Scandinavian Journal of Primary Health Care · doi:10.3109/02813431003765455 · Cited by 107
Medication Errors: Why they happen, and how they can be prevented.
Hughes, R. G., & Ortíz, E. (2005) · AJN American Journal of Nursing · doi:10.1097/00000446-200503001-00005 · Cited by 104
Pharmacoeconomic Evaluation of a Pharmacist‐Managed Hypertension Clinic
Okamoto, M. P., & Nakahiro, R. K. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.17.1337.34424 · Cited by 99
Latif, A., Pollock, K., & Boardman, H. (2011) · Patient Education and Counseling · doi:10.1016/j.pec.2011.05.007 · Cited by 97
Cost-outcome description of clinical pharmacist interventions in a university teaching hospital
Gallagher, J. R., Byrne, S., Woods, N., Lynch, D., & McCarthy, S. (2014) · BMC Health Services Research · doi:10.1186/1472-6963-14-177 · Cited by 97
Self-citationFertleman, M. B. (2005) · BMJ Quality & Safety · doi:10.1136/qshc.2004.011759 · Cited by 94
Elliott, W. J. (2008) · Yearbook of Cardiology · doi:10.1016/s0145-4145(08)05023-5 · Cited by 88
Optimizing pharmacotherapy in elderly patients: the role of pharmacists
Lee, J. K., Alshehri, S. O., Kutbi, H. I., & Martin, J. R. (2015) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s70404 · Cited by 87
Point-of-Care Testing: Future of Chronic Disease State Management?
Goble, J. A., & Rocafort, P. T. (2015) · Journal of Pharmacy Practice · doi:10.1177/0897190015587696 · Cited by 76
Krass, I., Mitchell, B., Clarke, P., Brillant, M., Dienaar, R., Hughes, J., Lau, P. M.-Y., Peterson, G. M., Stewart, K., Taylor, S. E., et al. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.06.022 · Cited by 70
Clinical and economic outcomes of pharmacist-managed antimicrobial prophylaxis in surgical patients
Bond, C., & Raehl, C. L. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060631 · Cited by 67
Development and clinical outcomes of pharmacist-managed diabetes care clinics
Morello, C. M., Zadvorny, E. B., Cording, M. A., Suemoto, R. T., Skog, J., & Harari, A. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050430 · Cited by 63
Paudyal, V., Hansford, D., Cunningham, S., & Stewart, D. C. (2011) · Health Policy · doi:10.1016/j.healthpol.2011.05.010 · Cited by 63
Chui, M. A., Stone, J. A., Martin, B. A., Croes, K. D., & Thorpe, J. M. (2013) · The Gerontologist · doi:10.1093/geront/gnt130 · Cited by 51
Including pharmacists on consultant-led ward rounds: a prospective non-randomised controlled trial
Miller, G., Franklin, B. D., & Jacklin, A. (2011) · Clinical Medicine · doi:10.7861/clinmedicine.11-4-312 · Cited by 42
Impact of an Emergency Department Pharmacist on Prescribing Errors in an Australian Hospital
deClifford, J., Caplygin, F. M., Lam, S. S., & Leung, B. K. (2007) · Journal of Pharmacy Practice and Research · doi:10.1002/j.2055-2335.2007.tb00766.x · Cited by 33
Hawes, E. M., Misita, C. P., Burkhart, J. I., McKnight, L., Deyo, Z. M., Lee, R.-A., Howard, C., & Eckel, S. F. (2016) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp150771 · Cited by 32
A Cost-Effectiveness Evaluation of Hospital Discharge Counseling by Pharmacists
Chinthammit, C., Armstrong, E. P., & Warholak, T. L. (2011) · Journal of Pharmacy Practice · doi:10.1177/0897190011418512 · Cited by 28
Perceived facilitators to change in hospital pharmacy practice in England
Auta, A., Maz, J., & Strickland–Hodge, B. (2015) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-015-0153-9 · Cited by 26
Hughes, R. G., & Ortíz, E. (2005) · Journal of Infusion Nursing · doi:10.1097/00129804-200503001-00005 · Cited by 23
An agenda for UK clinical pharmacology: Pharmacoeconomics
Hughes, D. A. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04247.x · Cited by 19
From NCE to NICE: the role of pharmacoeconomics
Hughes, D. A. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03708.x · Cited by 15
Erwin, P. B., Pitlick, M. K., & Peters, G. L. (2015) · Diabetes Spectrum · doi:10.2337/diaspect.28.4.237 · Cited by 5
(2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000180877.21709.d4 · Cited by 5
Cited by
A Systematic Review of Pharmacist-Led Antimicrobial Stewardship Programs in Sub-Saharan Africa
Otieno, P. A., Campbell, S., Maley, S., Obinju Arunga, T., & Otieno Okumu, M. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/3639943 · Cited by 92
Narang, P., Garg, V., & Sharma, A. (2023) · Discover Health Systems · doi:10.1007/s44250-023-00032-y · Cited by 29
Metadata
- Authors
- Dalton, K., & Byrne, S.
- Venue
- Integrated Pharmacy Research and Practice
- Publisher
- Informa UK Limited
- Published
- 2017-01
- Volume
- Volume 6
- Pages
- 37-46
- ISSN
- 2230-5254 (ISSN-L)
- OpenAlex
- W2581684376
- Cited by
- 449
- References
- 81
- FWCI
- 16.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.